tom's theory on the options., page-7

re: re:sbpo action as :Maxwell Smart" would say:
would you believe re-issue at .1c (not 1 cent) with expiry of 31/12/2003 and exercise price of 20c?
Time will tell.....if in fact this contingency plan is even needed.
Human trials in USA due for completion mid/late May and with rest of documentation in place with FDA = expect approval within 10-14 days of trial completion.
Do your own research at their website.